News|Articles|November 14, 2023

Infection Intel: AstraZeneca, DayZero and Oxford Nanopore, and More

Staying Ahead with Company Updates and Product Innovations. This week's news is from AstraZeneca, DayZero and Oxford Nanopore, Ohmnilab, and NIH.

Infection Intel is the column for Infection Control Today® (ICT®) that covers the latest news, including updates on product developments, mergers, and more from companies in the infection control and prevention field.

Newsletter

Stay prepared and protected with the Infection Control Today newsletter, delivering essential updates, best practices, and expert insights for infection prevention professionals.

Subscribe

Related Content

Copacabana Beach and Ipanema Beach in Rio de Janeiro, Brazil (Adobe Stock 193839900 by f11photo)

Latest CME

Multimedia

Empowering HIV Management: Evidence-Based Prevention and Treatment Strategies

Onyema Ogbuagu, MD, FACP, FIDSA

Infection Intel: AstraZeneca, DayZero and Oxford Nanopore, and More

Related Content

AIDS 2026: Malawi Targets the “Last Mile” of HIV Epidemic Control Through Community Care

AIDS 2026: Closing the Last-Mile Gap: Bringing HIV Care From Malawi’s Clinics Into Children’s Homes

Bug of the Month: You Never See Me Coming

From “Gotcha” to Coaching: Using RTLS to Improve Hand Hygiene

AIDS 2026: Malawi Program Achieves 10-fold Reduction in HIV Positivity Among Exposed Infants